David Turkaly
Stock Analyst at Citizens
(2.13)
# 2,800
Out of 5,182 analysts
149
Total ratings
37.23%
Success rate
-4.37%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TELA TELA Bio | Maintains: Market Outperform | $5 → $3 | $0.56 | +435.43% | 8 | Mar 27, 2026 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $78 → $85 | $81.67 | +4.08% | 11 | Feb 27, 2026 | |
| AXGN Axogen | Maintains: Market Outperform | $34 → $42 | $33.47 | +25.49% | 9 | Feb 24, 2026 | |
| MDXG MiMedx Group | Initiates: Market Outperform | $10 | $3.92 | +155.10% | 1 | Feb 23, 2026 | |
| SYK Stryker | Upgrades: Market Outperform | $440 | $347.24 | +26.71% | 4 | Dec 19, 2025 | |
| APYX Apyx Medical | Upgrades: Market Outperform | $8 | $3.88 | +106.19% | 6 | Nov 12, 2025 | |
| KIDS OrthoPediatrics | Maintains: Market Outperform | $35 → $25 | $16.95 | +47.49% | 12 | Oct 10, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $12.65 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $92.98 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $59.27 | +68.72% | 12 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $265 → $280 | $224.85 | +24.53% | 18 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $35 → $25 | $10.24 | +144.14% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $62 → $55 | $24.86 | +121.24% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $140 → $125 | $95.34 | +31.11% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $400 → $500 | $402.24 | +24.30% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $123.18 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $14.00 | +128.57% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $5.15 | +210.68% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $1.39 | +115.83% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $8.72 | -42.66% | 1 | Oct 6, 2017 |
TELA Bio
Mar 27, 2026
Maintains: Market Outperform
Price Target: $5 → $3
Current: $0.56
Upside: +435.43%
Lantheus Holdings
Feb 27, 2026
Maintains: Market Outperform
Price Target: $78 → $85
Current: $81.67
Upside: +4.08%
Axogen
Feb 24, 2026
Maintains: Market Outperform
Price Target: $34 → $42
Current: $33.47
Upside: +25.49%
MiMedx Group
Feb 23, 2026
Initiates: Market Outperform
Price Target: $10
Current: $3.92
Upside: +155.10%
Stryker
Dec 19, 2025
Upgrades: Market Outperform
Price Target: $440
Current: $347.24
Upside: +26.71%
Apyx Medical
Nov 12, 2025
Upgrades: Market Outperform
Price Target: $8
Current: $3.88
Upside: +106.19%
OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $16.95
Upside: +47.49%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $12.65
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $92.98
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $59.27
Upside: +68.72%
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $224.85
Upside: +24.53%
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $10.24
Upside: +144.14%
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $24.86
Upside: +121.24%
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $95.34
Upside: +31.11%
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $402.24
Upside: +24.30%
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $123.18
Upside: -
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $14.00
Upside: +128.57%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $5.15
Upside: +210.68%
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $1.39
Upside: +115.83%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $8.72
Upside: -42.66%